MedTech Investment in 2025: What Founders Need to Know About the Economic Landscape

The MedTech ecosystem has always thrived on bold ideas and breakthrough innovation—but those aren’t the only forces shaping success. In today’s market, economic conditions and capital trends are playing an increasingly powerful role in determining which companies thrive, which struggle, and which get funded at all.

That’s why our latest episode of the MedTech Step Up Webinar Series, “MedTech Investment & Economic Outlook”, takes a deep dive into what’s happening behind the scenes in venture capital, banking, and global economics and what it means for anyone building in MedTech today.

Whether you're raising now, planning a future round, or simply trying to understand the landscape you're operating in, this episode delivers insight you won’t find on a pitch deck.

Where the Capital Is (and Isn’t) Flowing

For many early stage companies, the assumption is that if they just build something great, the money will follow. But the reality is more complex. Economic factors from interest rates to market volatility are deeply influencing how and where investors deploy capital.

This episode breaks down:

• The current appetite for risk across different types of investors

• How sector focus is shifting within MedTech (and why)

• What early-stage vs. growth-stage capital looks like in 2025

• How founders can position their raise based on market timing

And perhaps most importantly: how to remain fundable even as the rules keep changing.

A Rare Look Inside the Minds of Investors

This is more than just a market update. Hosted by Cristiano Fontana, Head of Advisory, and Joseph Snyder, Co- Founder and Head of Talent at Lifeblood, the webinar features a powerhouse panel of experts who work directly with funds, founders, and financial institutions across the globe.

Guests include:

• David Uffer, Managing Director, Trinity Life Sciences

• Jonathan Norris, Managing Director, VC Relationship Management, HSBC Innovation Banking

• Diana Saraceni, Founder & Managing Partner, Panakes Partners

Each guest brings a unique angle ranging from investor strategy and fund formation to cross-border deal flow and early-stage MedTech trends.

Why This Webinar Matters Right Now

Understanding the broader capital environment gives founders a competitive edge. When you know what investors are reacting to, what metrics they’re watching, and how the macro picture is evolving, you’re better equipped to time your raise, shape your story, and manage expectations.

In a space where so much is outside your control, insight like this helps you focus on what is in your control and make smarter, more strategic decisions.

👉 Watch the full episode here: www.lifeblood.com/webinar

Lifeblood is a MedTech talent recruitment and business advisory firm helping companies become truly venture-backable. We work alongside founders to build high-performing teams, develop clear growth strategies, and prepare for capital raises with confidence.

Explore more at www.lifeblood.com.